Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States

Journal of the American Society of Nephrology

Volumn 13, Issue 7, 2002, Pages 1889-1893

  Ahuja, Tejinder S ^a   Grady, James ^a   Khan, Shilpi ^a  

^a 4200 John Sealy Annex   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SURVIVAL RATE; UNITED STATES;

EID: 0036287766     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000019773.43765.BF     Document Type: Article

References (29)

1. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome
2. Glomerular lesions in the acquired immunodeficiency syndrome
3. The types of renal disease in the acquired immunodeficiency syndrome
4. Pathology of HIV-associated nephropathy: A detailed morphologic and comparative study
5. Is the prevalence of HIV-associated nephropathy decreasing?
6. Prevalence of HIV-associated nephropathy in autopsies of HIV-1-infected patients
7. The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy
8. Outcome of patients with human immunodeficiency virus on maintenance hemodialysis
9. Survival of human immunodeficiency virus-infected patients on maintenance dialysis
10. Outcome of HIV infected patients on continuous ambulatory peritoneal dialysis
11. Continuous ambulatory peritoneal dialysis and survival of HIV infected patients with end-stage renal disease
12. Predictors of survival in HIV-infected patients on hemodialysis
13. Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: Has the outcome changed in the 1990s?
14. Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients
15. Declining morbidity and human immunodeficiency virus Infection
16. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration
17. Update: Trends in AIDS incidence - United States, 1996
18. Plasma interleukin-1 activity during hemodialysis: The influence of dialysis membrane
19. Descamps, Latscha B: Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor
20. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B
21. Interleukin-6 gene expression in peripheral blood mononuclear cells from patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis
22. Interleukin-6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcription and post-transcriptional mechanisms
23. An appraisal of antiretroviral drugs in hemodialysis
24. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men
25. Causes of death in dialysis patients: Racial and gender differences
26. Excerpts from the USRDS 2000 Annual Data Report: Atlas of end-stage renal disease in the United States
27. HIV-associated nephropathy is a late, not early, manifestation of HIV infection